Inventor · disambiguated record
Mark L. Witten
Also filed as: WITTEN MARK L
4 granted patents·10 pending applications·49 citations·filing 1997–2010
74Inventor score
Top patents by PatentIndex Score
14 records- 0168US5945508ASubstance P treatment for immunostimulationFiled 1997·Granted Aug 31, 1999·26 cites·17 claims
- 0261US8628625B2Method of detection/extraction, and related detection/extraction deviceWITTEN MARK L·Filed 2007·Granted Jan 14, 2014·2 cites·19 claims
- 0359US5998376ASubstance P treatment for immunostimulationFiled 1998·Granted Dec 7, 1999·21 cites·7 claims
- 0448US2007238661A1Substance P treatment for hepatitis CWITTEN MARK L·Filed 2007·Application pending·0 cites
- 0545US2006153789A1Stimulation of hair regrowthWITTEN MARK L·Filed 2003·Application pending·0 cites
- 0641US2007155667A1Acute respiratory syndromesIMMUNEREGEN BIOSCIENCES INC·Filed 2004·Application pending·0 cites
- 0739US2008167248A1Anti-Aging Effects Of Substance PIMMUNEREGEN BIOSCIENCES INC·Filed 2005·Application pending·0 cites
- 0839US2008193403A1Inducing And Maintaining Hair ColorIMMUNEREGEN BIOSCIENCES INC·Filed 2005·Application pending·0 cites
- 0938US2007207123A1Amelioration of effects of cigarette smokeWITTEN MARK L·Filed 2003·Application pending·0 cites
- 1037US9719985B2Method of detection and related detection deviceWITTEN MARK L·Filed 2010·Granted Aug 1, 2017·0 cites·25 claims
- 1137US2009286744A1Treatment of asthmaIMMUNEREGEN BIOSCINECES INC·Filed 2006·Application pending·0 cites
- 1234US2008194487A1Treatment of Skin DiseasesWITTEN MARK L·Filed 2005·Application pending·0 cites
- 1333US2010267616A1Acute respiratory syndromesIMMUNEREGEN BIOSCIENCES INC·Filed 2010·Application pending·0 cites
- 1432US2008318869A1Method to Promote Wound HealingIMMUNEREGEN BIOSCIENCES INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mark L. Witten files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →